Tirzepatide or Retatrutide, an alternative, NOT a combination Tirzepatide and Retatrutide are competing multi-receptor molecules
has received research support for the University of Florida as principal investigator from Boehringer Ingelheim, Echosens, Inventiva, LabCorp and Perspectum and has served as a consultant for Aligos Therapeutics, Arrowhead, AstraZeneca, 89bio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Prosciento, Sagimet Biosciences, Siemens USA and Terns Pharmaceuticals
Extended stability testing and re-evaluation protocols: The tirzepatide cost can be significantly impacted by proper storage and handling techniques
AltRx's gradual dosing minimizes this compared to aggressive starts
Write the mcg/ml number on the vial with a marker
What constituted an appropriate deficit initially may need modification several months into treatment to continue progress safely